XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 17 - Operating Segment Information
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

NOTE 17 – Operating Segment Information:

 

The Company manages and reports the following segments:

 

Branded Products segment: Primarily through our signature marketing brands BAMKO® and HPI®, we produce and sell customized merchandising solutions, promotional products and branded uniform programs. Branded products are sold to customers in a wide range of industries, including retail, hotel, food service, entertainment, technology, transportation and other industries. The segment currently has sales offices in the United States, Canada, Brazil, the United Kingdom and Colombia, with support services in China and India.

 

Healthcare Apparel segment: Primarily through our signature marketing brands Fashion Seal Healthcare®, Wink™ and CID Resources, we manufacture (through third parties or in our own facilities) and sell a wide range of healthcare apparel, such as scrubs, lab coats, protective apparel and patient gowns. This segment sells healthcare service apparel to healthcare laundries, dealers, distributors and retailers primarily in the United States.

 

Contact Centers: Through multiple The Office Gurus® entities, including our subsidiaries in El Salvador, Belize, Jamaica, Dominican Republic and the United States (collectively, “TOG”), we provide outsourced, nearshore business process outsourcing, contact and call-center support services to North American customers.

 

Intersegment eliminations include the elimination of revenues and costs from services provided by the Contact Centers segment to the Company’s two other segments. Such costs are recognized as selling and administrative expenses in the Branded Products and Healthcare Apparel segments. Income and expenses related to corporate functions that are not specifically attributable to an individual reportable segment are presented within Other in the tables below.

 

No customer accounted for more than 10% of the Company’s total net sales in 2023 or 2022.

 

During the fourth quarter of 2023, our chief operating decision maker began to evaluate the performance of our segments using Segment Adjusted EBITDA instead of income before income taxes. The Company has modified its presentation of segment performance to be consistent with this change, including prior periods presented for consistent and comparable presentation. Amounts included in income (loss) before income tax expense and excluded from Segment Adjusted EBITDA include: interest expense, depreciation and amortization expense, impairment charges and the other items not tied to the operational performance of the segment.

 

The following tables set forth financial information related to the Company’s operating segments (in thousands):

 

   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

As of and For the Year Ended December 31, 2023:

                                               

Net sales

  $ 342,680     $ 113,878     $ 91,500     $ (4,756 )   $ -     $ 543,302  

Segment Adjusted EBITDA

    33,146       7,997       12,408       -       (20,069 )   $ 33,482  

Supplemental information:

                                               

Depreciation and amortization

  $ 6,744     $ 3,925     $ 2,942     $ -     $ 384     $ 13,995  

Capital expenditures

  $ 2,550     $ 960     $ 1,392     $ -     $ 61     $ 4,963  

Total assets

  $ 218,018     $ 131,168     $ 40,941     $ -     $ 32,323     $ 422,450  
                                                 
    Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  

As of and For the Year Ended December 31, 2022:

                                               

Net sales

  $ 387,931     $ 113,321     $ 84,218     $ (6,639 )   $ -     $ 578,831  

Segment Adjusted EBITDA

    31,144       (2,747 )     18,521       -       (18,991 )     27,927  

Supplemental information:

                                               

Depreciation and amortization

  $ 6,465     $ 3,946     $ 2,373     $ -     $ 220     $ 13,004  

Capital expenditures

  $ 4,643     $ 1,169     $ 4,876     $ -     $ 330     $ 11,018  

Total assets

  $ 224,116     $ 150,335     $ 43,368     $ -     $ 39,122     $ 456,941  

 

 

The following table reconciles total Segment Adjusted EBITDA to income (loss) before income tax expense:

 

   

Years Ended December 31,

 
   

2023

   

2022

 

Income (loss) before income tax expense

  $ 9,769     $ (38,035 )

Interest expense

    9,718       4,894  

Depreciation and amortization

    13,995       13,004  

Goodwill impairment charge

    -       45,918  

Intangible assets impairment charge

    -       5,581  

Gain on sale of property, plant and equipment

    -       (3,435 )

Segment Adjusted EBITDA

  $ 33,482     $ 27,927